Evaluation of the effects of adolescent health promotion training package on treatment of poly cystic ovary disease

Not Applicable

Conditions: Polycystic ovarian syndrome
poly cystic ovarian syndrome.
E28.2

Registration Number: IRCT20200114046123N1

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 120

Inclusion Criteria

Written parental and student agreement
Girls ages 14 to 18 who are single and without sexual relation
At least 2 years passed from the juvenile menarche
According to ASRM criteria, 2 items of PCOS symptoms were diagnosed
Be healthy in terms of all diseases including liver, kidney, thyroid, heart and skeletal diseases
Have not taken any female hormone or metformin medication for at least three months before entering the study
Have no smoking at least three months before the intervention
Do not use drugs or alcohol
Not have severe mental illness (which requires medication)
Do not exercise professionally or attend school sports team
Do not follow a specific diet

Exclusion Criteria

Adolescents who failed to perform 1/3 of the recommended physical activities per month for any reason
Adolescents who for any reason failed to attend 1/3 of the classes held at the school.
Adolescents who have not completed any form of physical activity and diet assessment for at least one month for any reason.
Adolescents who affected by a specific illness or need to take a particular drug after entering the plan.
Adolescents who they or their parents are reluctant to continue in the project for any reason.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ife style modification in adolescent with poly cystic ovarian syndrome. Timepoint: before intervention, 6 and 12 after intervention. Method of measurement: diet and physical activity questionnaire.;Menstrual cycleregularity,. Timepoint: Before intervention and 6, 12 months after intervention. Method of measurement: Menstrual cycles are <21 or more than 35 days or have <8 cycles per year will be considered irregular.;Hirsutism status. Timepoint: Before intervention and 6, 12 months after intervention. Method of measurement: The Ferriman–Gallwey scale will be used for Hirsutism status; a score of 1–4 is given for nine areas of the body. A total score <9 is considered normal, a score of 9–15 indicates mild Hirsutism, and a score >15 indicates moderate or severe Hirsutism.;Anthropometric index. Timepoint: Before intervention and 6, 12 months after intervention. Method of measurement: weight,height, waist, and hip circumstance.

Secondary Outcome Measures

Name	Time	Method
Blood bio markers. Timepoint: before intervention and after 12 months. Method of measurement: Blood test.;Sonography Items. Timepoint: before intervention and after 12 months. Method of measurement: Transabdominal Sonography.